+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Very low-intensity anticoagulant therapy in elderly cardioembolic stroke patients with nonvalvular atrial fibrillation



Very low-intensity anticoagulant therapy in elderly cardioembolic stroke patients with nonvalvular atrial fibrillation



Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 31(9): 711-715



Several investigations revealed the significant effect of anticoagulant therapy for stroke prevention in patients with atrial fibrillation. However, in the elderly population, the optimal therapeutic strategy of secondary prevention of cardioembolic stroke is still controversial. We prospectively evaluated the efficacy and safety of very low-intensity anticoagulant therapy (target range, Thrombotest = 20-30%: INR = 1.47-1.81) for elderly cardioembolic stroke patients due to nonvalvular atrial fibrillation. Twenty cardioembolic stroke patients (average age 80.0) with nonvalvular atrial fibrillation were included in our study. Anticoagulant therapy began 5 of 7 days after the embolic event. The incidental rate of ischemic stroke recurrence and bleeding complication were evaluated. During mean follow-up of 14.7 month, the annual recurrent rate of ischemic stroke was 8.2% (cardioembolic stroke = 4.1%/year, atherothrombotic stroke = 0%/year, lacunar stroke = 4.1%/year), whereas one non-fatal gastrointestinal bleeding was observed. Our study suggested that even in the elderly population, very low-intensity anticoagulant therapy may be effective, and safe with respect to prevention of bleeding complications, for secondary cardioembolic stroke prevention.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034202409

Download citation: RISBibTeXText

PMID: 7823406


Related references

Detecting nonvalvular atrial fibrillation and anticoagulant therapy in cardioembolic ischemic stroke. Postgraduate Medicine 128(6): 620-628, 2017

Warfarin therapy for secondary prevention of cardioembolic stroke with nonvalvular atrial fibrillation--a retrospective study. Rinsho Shinkeigaku 33(8): 850-855, 1993

The role of anticoagulant therapy in hemorrhagic transformation of acute ischaemic stroke in nonvalvular atrial fibrillation patients. European Journal of Neurology 26(2): E24-E24, 2019

Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation. Circulation. Cardiovascular Quality and Outcomes 8(2 Suppl 1): S12-S20, 2015

The CHA(2)DS(2)-VASc score reflects clinical outcomes in nonvalvular atrial fibrillation patients with an initial cardioembolic stroke. Journal of Stroke and Cerebrovascular Diseases 22(8): E343-E346, 2014

Low Body Mass Index is a Poor Prognosis Factor in Cardioembolic Stroke Patients with NonValvular Atrial Fibrillation. Journal of Stroke and Cerebrovascular Diseases 27(11): 3155-3162, 2018

Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillation. Journal of the American College of Cardiology 61(17): 1790-1798, 2013

Incidence of ischemic stroke and systemic embolism in patients with hypertrophic cardiomyopathy, nonvalvular atrial fibrillation, CHA2DS2-VASc score of ≤1 and without anticoagulant therapy. Heart and Vessels 31(7): 1148-1153, 2017

Rate of antithrombotic drug use and clinical outcomes according to CHADS2 scores in patients with an initial cardioembolic stroke who had nonvalvular atrial fibrillation. Journal of Stroke and Cerebrovascular Diseases 22(6): 846-850, 2014

Oral Anticoagulant Therapy at Elderly Age: Heart Failure and Nonvalvular Atrial Fibrillation. American Journal of Geriatric Cardiology 5(1): 78-83, 1996

Late recurrence of embolic stroke after discontinuation of anticoagulant therapy in nonvalvular atrial fibrillation. Journal of Neurology 235(8): 499-500, 1988

Anticoagulant Use in High Stroke-Risk Patients With Nonvalvular Atrial Fibrillation. Consultant Pharmacist 33(9): 521-530, 2018

Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation A prospective, randomized, multicenter trial. Stroke 30(1): 241, 1999

Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation: A multicenter, prospective, randomized trial. Stroke 31(4): 817-821, 2000

Comparison of prothromboembolic state and cardiac function between nonvalvular atrial fibrillation cases and atrial fibrillation cases with valvular heart disease in severe cardioembolic stroke. Stroke 30(1): 246, 1999